Respiratory Tract Infection Treatment Market Size Report | 2031
呼吸道感染治疗市场规模预计将从 2023 年的 436 亿美元增至 2031 年的 691.3 亿美元；预计 2023 年至 2031 年复合年增长率为 5.93%。
呼吸道感染 (RTI) 是以下感染：鼻窦、喉咙、气道或肺部。 全球呼吸道感染治疗市场报告强调了推动市场的关键因素，并描述了知名参与者的发展。推动市场增长的关键因素包括全球呼吸道感染患病率不断上升、对呼吸道感染相关的认识以及与呼吸道感染相关的各种治疗方法的认识不断提高，以及与呼吸道感染治疗相关的临床试验数量的增加。然而，缺乏针对呼吸道治疗的研究以及与呼吸道感染药物相关的不良反应阻碍了市场的增长。此外，抗病毒治疗的出现预计将在未来几年带来新的全球呼吸道感染治疗市场趋势。
增长动力与制约因素：
老年人群呼吸系统疾病诊断需求不断上升
随着全球老年人口的增长，预计未来几年对呼吸系统疾病诊断的需求将会增加。例如，根据 2021 年 11 月发表在《英国药理学杂志》上的一篇文章，每年约有 1% 的英国人口被诊断出患有社区获得性肺炎 (CAP)。大约70%的病例发生在65岁以上的人群中，该年龄组的30天死亡率约为20%。因此，人口老龄化的增加和CAP等疾病发病率的增加预计将推动呼吸系统疾病治疗的需求，从而推动整体市场增长。
持续该领域的研究和开发产生了各种诊断测试和程序，将对未来几年市场的增长产生积极影响。创新的诊断方法预计将在预测期内为市场发展提供良好的机会。然而，与呼吸道感染药物相关的研究的缺乏和不良反应预计将限制全球呼吸道感染治疗市场的增长。
报告细分和范围：< /span>
全球呼吸道感染治疗市场分析考虑了以下细分：药物疾病适应症、给药途径、年龄组和分销渠道。根据药物，市场分为抗生素、非甾体抗炎药、止咳药、鼻减充血剂等。按疾病适应症，全球呼吸道感染治疗市场分为上呼吸道感染和下呼吸道感染。就给药途径而言，市场分为口服和肠胃外。根据年龄组，市场分为儿童和成人。根据分销渠道，全球呼吸道感染治疗市场分为医院药房、在线药房和零售药房。
细分分析：细分分析：
就药物而言，抗生素细分市场在 2023 年占据最大的全球呼吸道感染治疗市场份额。该细分市场预计 2023 年至 2031 年复合年增长率最高。呼吸道感染包括一系列疾病，包括支气管炎、肺炎和鼻窦炎，通常由细菌病原体引起。抗生素针对并消除这些有害细菌，减少炎症并促进更快的康复。治疗呼吸道感染的常用抗生素包括青霉素类、头孢菌素类、大环内酯类、氟喹诺酮类和四环素类，每种抗生素都有独特的作用机制和细菌靶标。
根据疾病适应症，下呼吸道感染细分市场到 2023 年将占据更大的市场份额。预计 2023 年至 2031 年复合年增长率将更高。下呼吸道感染 (LRTI) 是影响肺部和支气管的感染，通常由细菌、病毒或真菌病原体等。肺炎、支气管炎和细支气管炎等疾病通常表现出咳嗽、胸部不适、呼吸短促和发烧等症状，属于 LRTI 范畴。肺炎是一种严重的 LRTI，涉及肺组织的炎症和感染，导致肺实变（肺的某些区域或整个器官）和气体交换受损。
给药途径方面，口服给药在全球呼吸道感染治疗市场中占有较大份额；预计该细分市场在 2023 年至 2031 年期间将实现更高的复合年增长率。经常使用阿莫西林、阿奇霉素或多西环素等口服抗生素来对抗引起呼吸道感染的细菌病原体。除抗生素外，口服皮质类固醇还可减轻严重哮喘或慢性阻塞性肺疾病 (COPD) 恶化时的炎症。口服抗病毒药物（例如奥司他韦）用于治疗病毒性呼吸道感染（例如流感）。口服途径的共同优点包括给药方便、患者依从性好、药物分布全身。
从年龄组来看，成人群体所占比例较大2023年全球呼吸道感染治疗市场。儿科领域预计在2023-2031年期间将实现更高的复合年增长率。人们对儿童呼吸道感染早期诊断和治疗重要性的认识以及用于治疗的呼吸设备的进步等因素正在导致新的、更有效的治疗方案的开发。此外，对预防保健的日益关注也促进了儿科市场的增长。
在分销渠道方面，预计医院药房市场将占2023 年至 2031 年期间将占据重要的市场份额。医院药房是医疗保健系统的关键组成部分；它们在治疗需要静脉或肌肉注射药物的急性和严重呼吸道感染方面尤其发挥着至关重要的作用。这些药房负责采购、储存和分发抗生素、抗病毒药物、皮质类固醇和其他呼吸道感染治疗药物，并确保将其安全及时地运送到医院的住院和门诊机构。
区域分析：
人们对早期诊断和治疗重要性的认识不断增强未来几年，呼吸道感染可能会促进全球呼吸道感染治疗市场的增长。该市场分为北美、欧洲、亚太地区、中东和非洲、以及南美洲和中美洲。 2023 年，北美占据全球呼吸道感染治疗市场最大份额。由于该国呼吸道感染患病率上升，北美市场正在经历显着增长。空气污染、吸烟和拥挤的生活条件等因素导致该国呼吸道感染的高发率。呼吸道感染患病率的增加、医疗保健意识的提高以及政府的有利举措正在推动全球呼吸道感染治疗市场的增长。
< u>竞争格局和主要公司：
全球呼吸系统道感染治疗市场预测可以帮助利益相关者规划他们的增长战略。 Abbott Laboratories、AstraZeneca plc、Alembic Pharmaceuticals Ltd.、Boehringer Ingelheim International GmbH、GlaxoSmithKline plc、梯瓦制药工业有限公司、诺华公司、罗氏公司、赛诺菲公司、默克公司Co、Cipla 是全球呼吸道感染治疗市场报告中介绍的知名参与者之一。这些公司专注于各种战略（包括有机和无机），以满足不断增长的消费者需求并扩大其专业产品组合的产品范围。市场上公司采取的主要策略包括新技术发布、现有产品开发和地域扩张。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Respiratory diseases such as asthma, bronchitis, allergic rhinitis, pneumonia and sinusitis can seriously impair a person's physical functioning. Symptoms associated with both mild and severe diseases of these respiratory tracts include cough, wheezing, chest pain, difficulty breathing, and shortness of breath, congestion and, in severe cases, even death. These conditions cause significant morbidity and high costs to society. Treatment of the above respiratory disease is known as respiratory tract infection treatment.
The key factors driving the respiratory tract infection treatment market growth are the demand for the diagnosis of respiratory diseases owing to the rising prevalence of these diseases coupled with rising demand for OTC products. In addition, continuous research and development in this field has resulted in various diagnostic tests and procedures that will positively affect the growth of the market in the coming years.
The respiratory tract infection treatment market was valued at US$ 43.60 billion in 2023.
The respiratory tract infection treatment market is expected to be valued at US$ 69.13 billion in 2031.
The respiratory tract infection treatment market has major market players, including Abbott Laboratories, AstraZeneca plc, Alembic Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche AG, Sanofi S.A., Merck & Co and Cipla.
Based on drug, the market is segmented into Antibiotics, NSAIDs, Cough Suppressants, Nasal Decongestants, and Others. The antibiotics segment held the largest respiratory tract infection treatment market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.
Based on disease indication, the respiratory tract infection treatment market is segmented into LRTI and URTI. The LRTI is anticipated to hold a significant share by 2031.
The List of Companies - Respiratory Tract Infection Market
- Merck & Co
- Abbott
- AbbVie
- Sanofi
- GlaxoSmithKline plc
- F. Hoffmann La Roche Ltd.
- Pfizer, Inc.
- Novartis AG
- Teva Pharmaceuticals
- Boehringer Ingelheim GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For